0.9958 USD
-0.02 (-2.37%)
1.02 USD
+0.02 (+2.43%)
Taking everything into account, RNXT scores 3 out of 10 in our fundamental rating. RNXT was compared to 525 industry peers in the Biotechnology industry. RNXT has a great financial health rating, but its profitability evaluates not so good. RNXT has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
- RNXT had negative earnings in the past year.
- In the past year RNXT has reported a negative cash flow from operations.
- In the past 5 years RNXT always reported negative net income.
- In the past 5 years RNXT always reported negative operating cash flow.
1.2 Ratios
- Looking at the Return On Assets, with a value of -99.10%, RNXT is doing worse than 74.29% of the companies in the same industry.
- The Return On Equity of RNXT (-137.47%) is worse than 62.48% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -99.1% | ||
| ROE | -137.47% | ||
| ROIC | N/A |
ROA(3y)-314.19%
ROA(5y)-236.06%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- RNXT has a better Gross Margin (67.78%) than 80.95% of its industry peers.
- The Profit Margin and Operating Margin are not available for RNXT so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 67.78% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
- RNXT does not have a ROIC to compare to the WACC, probably because it is not profitable.
- Compared to 1 year ago, RNXT has more shares outstanding
- The number of shares outstanding for RNXT has been increased compared to 5 years ago.
- There is no outstanding debt for RNXT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
- RNXT has an Altman-Z score of -2.67. This is a bad value and indicates that RNXT is not financially healthy and even has some risk of bankruptcy.
- Looking at the Altman-Z score, with a value of -2.67, RNXT is in line with its industry, outperforming 47.81% of the companies in the same industry.
- RNXT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -2.67 |
ROIC/WACCN/A
WACC8.88%
2.3 Liquidity
- A Current Ratio of 5.83 indicates that RNXT has no problem at all paying its short term obligations.
- With a decent Current ratio value of 5.83, RNXT is doing good in the industry, outperforming 61.33% of the companies in the same industry.
- RNXT has a Quick Ratio of 5.68. This indicates that RNXT is financially healthy and has no problem in meeting its short term obligations.
- With a decent Quick ratio value of 5.68, RNXT is doing good in the industry, outperforming 61.52% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.83 | ||
| Quick Ratio | 5.68 |
3. Growth
3.1 Past
- RNXT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 36.21%, which is quite impressive.
EPS 1Y (TTM)36.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%20%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
3.2 Future
- Based on estimates for the next years, RNXT will show a very strong growth in Earnings Per Share. The EPS will grow by 22.56% on average per year.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y18.4%
EPS Next 2Y5.24%
EPS Next 3Y23.26%
EPS Next 5Y22.56%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
- RNXT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
- Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for RNXT. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- RNXT's earnings are expected to grow with 23.26% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y5.24%
EPS Next 3Y23.26%
5. Dividend
5.1 Amount
- RNXT does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
RENOVORX INC / RNXT FAQ
What is the ChartMill fundamental rating of RENOVORX INC (RNXT) stock?
ChartMill assigns a fundamental rating of 3 / 10 to RNXT.
What is the valuation status for RNXT stock?
ChartMill assigns a valuation rating of 1 / 10 to RENOVORX INC (RNXT). This can be considered as Overvalued.
What is the profitability of RNXT stock?
RENOVORX INC (RNXT) has a profitability rating of 1 / 10.
What is the earnings growth outlook for RENOVORX INC?
The Earnings per Share (EPS) of RENOVORX INC (RNXT) is expected to grow by 18.4% in the next year.